title: Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome.
abstract: An increasing number of reports suggest that Propionibacterium acnes can cause serious invasive infections. Currently, only limited data exist regarding the spectrum of invasive P. acnes infections. We conducted a non-selective cohort study at a tertiary hospital in the UK over a 9-year-period (2003-2012) investigating clinical manifestations, risk factors, management, and outcome of invasive P. acnes infections. Forty-nine cases were identified; the majority were neurosurgical infections and orthopaedic infections (n = 28 and n = 15 respectively). Only 2 cases had no predisposing factors; all neurosurgical and 93.3 % of orthopaedic cases had a history of previous surgery and/or trauma. Foreign material was in situ at the infection site in 59.3 % and 80.0 % of neurosurgical and orthopaedic cases respectively. All neurosurgical and orthopaedic cases required one or more surgical interventions to treat P. acnes infection, with or without concomitant antibiotic therapy; the duration of antibiotic therapy was significantly longer in the group of orthopaedic cases (median 53 vs 19 days; p = 0.0025). All tested P. acnes isolates were susceptible to penicillin, ampicillin and chloramphenicol; only 1 was clindamycin-resistant. Neurosurgical and orthopaedic infections account for the majority of invasive P. acnes infections. Most cases have predisposing factors, including previous surgery and/or trauma; spontaneous infections are rare. Foreign material is commonly present at the site of infection, indicating that the pathogenesis of invasive P. acnes infections likely involves biofilm formation. Since invasive P. acnes infections are associated with considerable morbidity, further studies are needed to establish effective prevention and optimal treatment strategies.
authors.affiliation: Academic Unit of Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK, m.tebruegge@soton.ac.uk.
authors.forename: M
authors.initials: M
authors.lastname: Tebruegge
authors.forename: C
authors.initials: C
authors.lastname: Jones
authors.forename: H
authors.initials: H
authors.lastname: de Graaf
authors.forename: P
authors.initials: P
authors.lastname: Sukhtankar
authors.forename: R N
authors.initials: RN
authors.lastname: Allan
authors.forename: R P
authors.initials: RP
authors.lastname: Howlin
authors.forename: D
authors.initials: D
authors.lastname: Browning
authors.forename: H
authors.initials: H
authors.lastname: Schuster
authors.forename: A
authors.initials: A
authors.lastname: Pallett
authors.forename: S
authors.initials: S
authors.lastname: Patel
authors.forename: S N
authors.initials: SN
authors.lastname: Faust
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011425:Propionibacterium acnes / Q000302:isolation & purification*; D012307:Risk Factors; D062606:Tertiary Care Centers; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents